Almac Concludes Commercial API Manufacturing Facility Expansion Plans
Advertisement
In response to client requirements, Almac’s expansion of their API manufacturing facility at its European Headquarters in Craigavon, UK is near completion, and will be operational by the end of the year. This upgrade includes installation of two 1,000L reactors and state-of-the-art pressure filter dryer, which allows production of GMP active pharmaceutical ingredients (API) up to 150kg batch size.
“Almac’s investment has further demonstrated our goal of being the outsourcing partner of choice through all stages of clinical development.” stated Denis Geffroy, VP Business Development. “We are delighted to have the scale to share the manufacturing journey with our clients from preclinical phase to full commercialisation.”